Outlook Therapeutics, Inc. (OTLK)
1.975
-0.02
(-1.25%)
USD |
NASDAQ |
Dec 12, 16:00
1.99
+0.02
(+0.76%)
After-Hours: 20:00
Outlook Therapeutics Shareholders Equity (Quarterly): -37.19M for June 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
| Theriva Biologics, Inc. | 6.738M |
| Oragenics, Inc. | 9.831M |
| NanoViricides, Inc. | 7.175M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 22.39M |
| Total Liabilities (Quarterly) | 59.58M |
| Debt to Equity Ratio | -0.933 |
| Current Ratio | 0.67 |
| Net Debt Paydown Yield | 2.89% |